TheEdgeResearch
Home / Stocks / PCHM

PharmChem, Inc. (PCHM)

OTC Healthcare Medical - Diagnostics & Research
$3.75 ▲ +0.27%
Market Cap
$22.0M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.67
52-Wk Range
2.95-3.98
CEO
Thompson Clark CPA
Country
US
Currency
USD

PharmChem, Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Fort Worth, TX, US. The stock last traded at $3.75, up 0.27% on the session, giving a market capitalisation of $22.0M. On trailing twelve-month figures it carries a trailing P/E of 12.50, a net margin of 22.7%. Its beta of 0.67 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
12.50
Price / Sales
3.61
Price / Book
8.11
EV / EBITDA
11.70
Gross margin
63.7%
Operating margin
27.3%
Net margin
22.7%
Return on equity
Debt / equity
0.02
Current ratio
4.70
Dividend yield
0.0%
Payout ratio
84.2%
Company profile
Exchange
Other OTC
Employees
9
IPO date
2021-01-08
Headquarters
Fort Worth, TX, US
About PharmChem, Inc.

PharmChem, Inc. manufactures and distributes the PharmChek Sweat Patch, a product designed for detecting the presence of illicit substances. This patch uses sweat as its sample source, offering an innovative alternative to conventional urine drug tests for identifying cocaine, opiates, amphetamines, PCP, and marijuana. The company is headquartered in Fort Worth, Texas.

Comparable companies

PharmChem, Inc. is most often compared with the following Healthcare names:

BFFTFEMMLFGRAMFHDSLFKBBTFKMSTFRTNXFUSNUVILGFVNNYF
More research on PCHM
PCHM technical analysis PCHM TheEdge Score Compare against peers
Open full interactive analysis & DCF →